In the trilogy of CMC (Chemistry, Manufacturing, and Controls), the final “C” is often underestimated but is arguably the most critical for ensuring that what we produce is consistent, safe, and regulatory-compliant. If chemistry defines the drug and manufacturing brings it to life, controls are what guarantee that the product remains reliable in every vial, tablet, or dose.

Controls are the immune system of pharmaceutical development. They detect deviations, defend against risks, and validate that every batch delivers on its promise.

What do we mean by “controls” in CMC?

The “controls” in CMC encompass a wide range of quality assurance (QA), quality control (QC), analytical testing, and regulatory documentation processes. These are not optional extras, they are embedded into every stage of drug development and commercial production.

Controls ensure that:

• Every product meets its specifications
• Every batch is reproducible
• Every anomaly is detected, investigated, and resolved
• Every step is traceable, documented, and auditable

In short, controls create trust, with regulators, with prescribers, and most importantly, with patients.

Core components of CMC controls

Analytical testing and specifications

Every drug product must be tested to ensure it meets predefined criteria for:

• Identity
• Purity
• Potency
• Impurities and degradations products

These parameters are outlined in the specification document. Analytical methods must be:

• Validated
• Robust and reproducible
• Fit for purpose across batches and environments

Stability studies and shelf-life determination

Drugs degrade over time, especially under stress conditions. To simulate and understand this, control teams perform stability testing under ICH guidelines:

• Long-term testing
• Accelerated testing
• Stress testing

These studies establish the expiration date and storage conditions, which are legally binding for manufacturers and distributors.

Good manufacturing practice (GMP) compliance

Controls ensure that every part of the production process adheres to GMP standards, including:

• Personnel qualifications and training
• Validated equipment and cleaning procedures
• Controlled environments
• Documented procedures and deviation management

This rigor isn’t just about passing audits. It’s about building systems where quality is embedded, not inspected in.

Batch records and traceability

Every batch of a drug must have a complete history:

• Raw material origins and testing
• Manufacturing and packaging steps
• In-process controls and deviations
• Final QC results and release authorization

This documentation allows manufacturers to trace any issue back to its source.

Regulatory role: Controls as the language of compliance

Controls form the backbone of regulatory submissions such as:

• Investigational New Drug (IND) applications
• New Drug Applications (NDA) or Marketing Authorization Applications (MAA)
• Annual reports, stability updates, and change control filings

Agencies like the FDA, EMA, and PMDA expect transparent, validated, and auditable data showing that the product meets safety and quality expectations at every stage of its lifecycle.

Modern trends: Data-driven and adaptive controls

The future of controls is increasingly digital and predictive:

• Real-Time Release Testing (RTRT)
• Process Analytical Technology (PAT)
• Digital Quality Systems
• AI-driven anomaly detection

These technologies promise faster release cycles, fewer failures, and more proactive compliance.

Controls turn process into product, and product into trust

In a world where patients depend on precision, safety, and consistency, the controls in CMC play a vital role. They don’t just catch errors, they prevent them, predict them, and prove that they’ve been addressed.

Controls are the final filter between a promising molecule and a reliable medicine. They bring confidence to regulators, clinicians, and patients alike.

So, while chemistry and manufacturing might get all the glory, it’s controls that ensure the promise of science becomes a trusted reality, batch after batch, dose after dose.

Interested in learning more?

Read Bengt’s full series on CMC, where he discusses each of Chemistry, Manufacturing, and Controls:

CMC in Drug Development: The Bridge from Lab to Market

The “C” in CMC: Why Chemistry Is the Cornerstone of Drug Development

The “M” in CMC: Manufacturing as the Engine Room of Drug Development

Share Via